We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-19 of 19 results
  1. Viral, genetic, and immune factors in the oncogenesis of adult T-cell leukemia/lymphoma

    Adult T-cell leukemia/lymphoma (ATL) is a malignancy of mature CD4 + T cells induced by human T-cell leukemia virus type I (HTLV-1). HTLV-1 maintains...

    Jun-ichirou Yasunaga in International Journal of Hematology
    Article 27 January 2023
  2. Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies

    Background

    Numerous vaccination research experiments have been conducted on non-primate hosts to prevent or control HTLV-1 infection. Therefore,...

    Niloofar Seighali, Arman Shafiee, ... Sayed-Hamidreza Mozhgani in BMC Infectious Diseases
    Article Open access 11 May 2023
  3. Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities

    Purpose of the Review

    Adult T-cell leukemia (ATL) is an aggressive chemo-resistant malignancy secondary to HTLV-1 retrovirus. Prognosis of ATL remains...

    Rita Hleihel, Abdou Akkouche, ... Hiba El Hajj in Current Oncology Reports
    Article 04 November 2021
  4. 3,3′,5-Triiodothyroacetic acid (TRIAC) induces embryonic ζ-globin expression via thyroid hormone receptor α

    The human ζ-globin gene ( HBZ ) is transcribed in primitive erythroid cells only during the embryonic stages of development. Reactivation of this...

    Huiqiao Chen, Zixuan Wang, ... Hao Yuan in Journal of Hematology & Oncology
    Article Open access 26 June 2021
  5. Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner

    Since the identification of the antisense protein of HTLV-2 (APH-2) and the demonstration that APH-2 mRNA is expressed in vivo in most HTLV-2...

    Louise Dubuisson, Florence Lormières, ... Renaud Mahieux in Oncogene
    Article 06 March 2018
  6. Super-enhancers: critical roles and therapeutic targets in hematologic malignancies

    Super-enhancers (SEs) in a broad range of human cell types are large clusters of enhancers with aberrant high levels of transcription factor binding,...

    Yunlu Jia, Wee-Joo Chng, Jianbiao Zhou in Journal of Hematology & Oncology
    Article Open access 16 July 2019
  7. HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4+ T cells

    Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic retrovirus that induces a fatal T-cell malignancy, adult T-cell leukemia (ATL). Among...

    A Kawatsuki, J-i Yasunaga, ... M Matsuoka in Oncogene
    Article 25 January 2016
  8. Metabolic reprogramming: a hallmark of viral oncogenesis

    More than 1 in 10 cases of cancer in the world are due to chronic viral infections. Viruses induce oncogenesis by targeting the same pathways known...

    P Lévy, B Bartosch in Oncogene
    Article 21 December 2015
  9. E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish

    Background

    Diet-induced hepatic steatosis is highly associated with nonalcoholic fatty liver disease, which is related to the development of metabolic...

    Yasuhito Shimada, Shisei Kuninaga, ... Toshio Tanaka in Nutrition & Metabolism
    Article Open access 20 May 2015
  10. HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells

    Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia (ATL). HTLV-1 bZIP factor (HBZ), the viral gene...

    G Ma, J Yasunaga, ... M Matsuoka in Oncogene
    Article 08 October 2012
  11. Molecular mechanisms of HTLV-1 infection and pathogenesis

    Human T cell leukemia virus type 1 (HTLV-1) is an etiological pathogen of several human diseases, including adult T-cell leukemia (ATL),...

    Junichiro Yasunaga, Masao Matsuoka in International Journal of Hematology
    Article 28 September 2011
  12. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy

    The human T-cell leukemia virus type 1 (HTLV-1) was the first retrovirus discovered to be causative of a human cancer, adult T-cell leukemia. The...

    M Matsuoka, K-T Jeang in Oncogene
    Article 29 November 2010
  13. TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients

    T-cell prolymphocytic leukemia (T-PLL) is a rare type of peripheral T-cell leukemia. In this study, we examined the clinical and biological...

    Akihiko Yokohama, Akio Saitoh, ... Norifumi Tsukamoto in International Journal of Hematology
    Article 23 December 2011
  14. Multiple facets of junD gene expression are atypical among AP-1 family members

    JunD is a versatile AP-1 transcription factor that can activate or repress a diverse collection of target genes. Precise control of junD expression...

    J M Hernandez, D H Floyd, ... K Boris-Lawrie in Oncogene
    Article 21 April 2008
  15. Implication of the HTLV- I bZIP Factor Gene in the Leukemogenesis of Adult T-Cell Leukemia

    Adult T-cell leukemia (ATL) is a leukemia derived from CD4 + mature T-cells and induced by human T-cell leukemia virus type I (HTLV-I) infection....

    Yorifumi Satou, Masao Matsuoka in International Journal of Hematology
    Article 01 August 2007
  16. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein

    Disruption of transcriptional control of cellular genes by human T-cell leukemia virus type-1 (HTLV-1) is thought to be associated, at least in part,...

    Jun Matsumoto, Takayuki Ohshima, ... Kunitada Shimotohno in Oncogene
    Article 13 December 2004
  17. T-Cell Control by Human T-Cell Leukemia/Lymphoma Virus Type 1

    Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) causes neoplastic transformation of human T-cells in a small number of infected individuals...

    Genoveffa Franchini, Risaku Fukumoto, Jake R. Fullen in International Journal of Hematology
    Article 01 November 2003
Did you find what you were looking for? Share feedback.